Indications / Non-small cell lung cancer · Breast cancer · Pancreatic cancer · Colorectal cancer · Acute myeloid leukemia · Chronic myeloid leukemia · Multiple myeloma · Glioblastoma · Glioma · Neuroblastoma · Medulloblastoma · Diffuse midline glioma (DIPG) · Ependymoma · Atypical teratoid rhabdoid tumour (AT/RT) · Childhood acute lymphoblastic leukemia · Ewing sarcoma · Osteosarcoma · Rhabdomyosarcoma
Diffuse midline glioma (DIPG)
H3 K27-altered tumours of the brainstem and midline, with no curative treatment: ONC201 and cell therapy trials.
SITC Annual Meeting 2026
4–8 Nov 2026, Phoenix · Journal for ImmunoTherapy of Cancer 14 (Suppl 2 and 3), open access
1,109 regular and 19 late-breaking abstracts are in Crossref as open-access JITC supplement records (CC BY-NC); the supplement may still be filling in.
Indexed in Crossref
2 abstracts matching diffuse midline glioma (dipg) from the meeting's journal supplement, fetched live from Crossref 2026-11-12 08:17 UTC. This is a keyword search, not the complete abstract book.
- 323Adaptive anti-CAR immunity compromises the durability of GD2-CAR T cell therapy in diffuse midline gliomaKevin M Reynolds, Camille F Petrakian, Yiyun Chen, Elena Sotillo et al.
- 656Targeting tumor stress for adoptive cell therapy: ONC201 enhances NK cell activity against diffuse midline gliomasVidya Gopalakrishnan, Donghang Cheng, Patrick Zhang, Rafet Basar et al.